Abstract:Effective and accurate diagnosis of Alzheimer's disease (AD), as well as its prodromal stage (i.e., mild cognitive impairment (MCI)), has attracted more and more attention recently. So far, multiple biomarkers have been shown to be sensitive to the diagnosis of AD and MCI, i.e., structural MR imaging (MRI) for brain atrophy measurement, functional imaging (e.g., FDG-PET) for hypometabolism quantification, and cerebrospinal fluid (CSF) for quantification of specific proteins. However, most existing research focuses on only a single modality of biomarkers for diagnosis of AD and MCI, although recent studies have shown that different biomarkers may provide complementary information for the diagnosis of AD and MCI. In this paper, we propose to combine three modalities of biomarkers, i.e., MRI, FDG-PET, and CSF biomarkers, to discriminate between AD (or MCI) and healthy controls, using a kernel combination method. Specifically, ADNI baseline MRI, FDG-PET, and CSF data from 51AD patients, 99 MCI patients (including 43 MCI converters who had converted to AD within 18 months and 56 MCI non-converters who had not converted to AD within 18 months), and 52 healthy controls are used for development and validation of our proposed multimodal classification method. In particular, for each MR or FDG-PET image, 93 volumetric features are extracted from the 93 regions of interest (ROIs), automatically labeled by an atlas warping algorithm. For CSF biomarkers, their original values are directly used as features. Then, a linear support vector machine (SVM) is adopted to evaluate the classification accuracy, using a 10-fold cross-validation. As a result, for classifying AD from healthy controls, we achieve a classification accuracy of 93.2% (with a sensitivity of 93% and a specificity of 93.3%) when combining all three modalities of biomarkers, and only 86.5% when using even the best individual modality of biomarkers. Similarly, for classifying MCI from healthy controls, we achieve a classification accuracy of 76.4% (with a sensitivity of 81.8% and a specificity of 66%) for our combined method, and only 72% even using the best individual modality of biomarkers. Further analysis on MCI sensitivity of our combined method indicates that 91.5% of MCI converters and 73.4% of MCI non-converters are correctly classified. Moreover, we also evaluate the classification performance when employing a feature selection method to select the most discriminative MR and FDG-PET features. Again, our combined method shows considerably better performance, compared to the case of using an individual modality of biomarkers.

ASMFS: Adaptive-Similarity-based Multi-modality Feature Selection for Classification of Alzheimer's Disease

Inter-modality Relationship Constrained Multi-Modality Multi-Task Feature Selection for Alzheimer's Disease and Mild Cognitive Impairment Identification.

A feature-aware multimodal framework with auto-fusion for Alzheimer's disease diagnosis

Label-aligned multi-task feature learning for multimodal classification of Alzheimer's disease and mild cognitive impairment

Multi-modality sparse representation-based classification for Alzheimer's disease and mild cognitive impairment

Enhanced Multimodal Low-rank Embedding based Feature Selection Model for Multimodal Alzheimer's Disease Diagnosis

Self-paced Semi-Supervised Feature Selection with Application to Multi-Modal Alzheimer’s Disease Classification

Multimodal classification of Alzheimer's disease and mild cognitive impairment

Enhanced Multimodal Low-rank Embedding Based Feature Selection Model for Multimodal Alzheimer’s Disease Diagnosis

Tensor-Based Multi-Modality Feature Selection and Regression for Alzheimer's Disease Diagnosis

Inter-modality Relationship Constrained Multi-Task Feature Selection for AD/MCI Classification.

Multi-modal cross-attention network for Alzheimer's disease diagnosis with multi-modality data

Multi-level Graph Regularized Robust Multi-Modal Feature Selection for Alzheimer’s Disease Classification

A hybrid multimodal machine learning model for Detecting Alzheimer's disease

Multimodal Identification of Alzheimer's Disease: A Review

Sparse Discriminative Feature Selection for Multi-class Alzheimer’s Disease Classification

Deep learning and multimodal feature fusion for the aided diagnosis of Alzheimer's disease

Multi-modal latent space inducing ensemble SVM classifier for early dementia diagnosis with neuroimaging data

A Progressive Single-Modality to Multi-Modality Classification Framework for Alzheimer's Disease Sub-type Diagnosis

Toward Robust Early Detection of Alzheimer's Disease via an Integrated Multimodal Learning Approach

Multi-modal Self-paced Locality Preserving Learning for Diagnosis of Alzheimer’s Disease